Latest News

Friday, March 24, 2017 | Psoriasis, Research and Publications

Study: Severe Psoriasis More Common in Men

Severe psoriasis predominantly affects men, according to a new study in the American Journal of Clinical Dermatology. In the study of 5,438 Swedish psoriasis patients, women had significantly …

Read the full story

Friday, March 24, 2017 | FDA Approval/Clearance, Skin Cancer

FDA Approves First Treatment for Rare Form of Skin Cancer

The FDA granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have …

Read the full story

Wednesday, March 22, 2017 | Research and Publications

Positive Results Announced from SebuDerm Gel Study in Treatment of Seborrheic Dermatitis

The results of a clinical study evaluating the impact of Sonoma Pharmaceuticals, Inc.'s SebuDerm (topical hypochlorous acid) gel in the treatment of mild to moderate facial and scalp seborrheic de…

Read the full story

Monday, March 20, 2017 | Atopic Dermatitis, Pediatric, Research and Publications

No Antibiotics Needed For Mild Infected Eczema in Kids

Oral or topical antibiotics are not effective for treating milder clinically infected eczema in children, a new study shows. In the study of 113 children with clinical, non-severely infected eczema…

Read the full story

Monday, March 20, 2017 | Healthcare Trends, Research and Publications

Education Credits Available: ABCs of Nitric Oxide in the Skin

A free, online educational program intended to provide participants increased knowledge regarding the role of NO in maintaining a variety of physiologic processes has been launched. The program i…

Read the full story

Monday, March 20, 2017 | Research and Publications

5α-Reductase Inhibitors Not Associated with Increased Suicide Risk in Older Men

Using 5α- reductase inhibitors was not associated with increased suicide risk in a group of older men, according to new research in JAMA Internal Medicine. Risks for self-harm and depression …

Read the full story

Monday, March 20, 2017 | FDA Approval/Clearance, Fillers & Injectables, Allergan

FDA Approved Juvéderm Vollure XC for Correction of Facial Wrinkles and Folds

The FDA has approved Allergan plc's Juvéderm Vollure XC for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21. In the US piv…

Read the full story

Friday, March 17, 2017 | Skin Care, Product Launches and Updates, Topix

Topix Pharmaceuticals Rolls Out Replenix RetinolForte Treatment Serum

Topix Pharmaceuticals is adding Replenix® RetinolForte Treatment Serum to their portfolio of offerings. The serum’s patent-pending, time-released Micropolymer delivery system deposits ret…

Read the full story

Friday, March 17, 2017 | Skin Care, Product Launches and Updates, Ferndale

Heliocare Spotlights Improved Formulation: Vegan, Gluten-free, and Dye-free

Heliocare Daily Use Antioxidant Formula, a clinically proven, natural dietary supplement with antioxidant effects on the skin, has been updated to be vegan, gluten-free, and free of artificial dyes. T…

Read the full story

Thursday, March 16, 2017 | Skin Care, Product Launches and Updates

Dermalogica's Newest Add Targets Tired Eyes

Dermalogica is launching their newest product -- a two-in-one eye masque that targets tired eyes. The Stress Positive Eye Lift officially launches in early April 2017. Put on with a cooling ma…

Read the full story

Thursday, March 16, 2017 | Skin Cancer, American Academy of Dermatology

AAD Throws Some Shade At 26 Schools With 2017 Shade Structure Grants

The American Academy of Dermatology (AAD) awarded shade structure grants to 26 schools and non-profit organizations across the country. Since its launch in 2000, the AAD’s Shade Structure Gra…

Read the full story

Tuesday, March 14, 2017 | Product Launches and Updates, Hair loss

RepliCel’s Baldness Cure Performs Well In First In-Human Trial

The first in-human study of RepliCel Life Sciences Inc’s investigational baldness cure, RCH-01, confirms the therapy’s safety and demonstrates strong efficacy signals, the company reports.…

Read the full story

Tuesday, March 14, 2017 | Fillers & Injectables, Allergan

Survey Findings: Submental Region Major Pain Point for Patients

Close to 50 percent of individuals are bothered by the appearance of the area under their chin, and many alter their behavior as a result, according to a new survey commissioned by Allergan plc. …

Read the full story

Tuesday, March 14, 2017 | Practice Management, CareCredit

ADAM Names Lori Skraba 2017 Practice Manager of the Year

The Association of Dermatology Administrators and Managers (ADAM)  named Lori Skraba of DuBois Dermatology and Cosmetics in DuBois, Pa., the recipient of the annual Practice Manager of the Year a…

Read the full story

Tuesday, March 14, 2017 | Business of Medicine, Earnings and Financials, Valeant NJ

Pershing Square Capital Management, L.P. Announces Sale of Its Investment In Valeant Pharmaceuticals International, Inc.

Pershing Square Capital Management, L.P. (“Pershing Square”) announced today that it has sold its investment in Valeant Pharmaceuticals International, Inc. (“Valeant”) (ticker:…

Read the full story
Load More
 Stock Price  Change 
 AbbVie $65.62  -0.05% 
 Allergan $237.33  0.87% 
 Amgen $165.74  -0.18% 
 Bayer AG $115.44  0.62% 
 Celgene $123.38  0.13% 
 Cutera $20.15  -0.49% 
 Cynosure $66.00  0.00% 
 GlaxoSmithKline $42.31  0.00% 
 Johnson and Johnson $125.48  -0.33% 
 Lily $84.18  -0.28% 
 Nestle $77.90  0.06% 
 Novartis $74.37  -0.08% 
 Pfizer $34.00  -0.85% 
 Proctor and Gamble $90.57  -0.22% 
 Taro $116.97  0.15% 
 Unilever $50.26  0.38% 
 Valeant $10.75  -1.01%